Clinical trials: Bundibugyo Virus Disease
- Condition Bundibugyo Virus Disease
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Ebola-Bundibugyo Virus Disease (Ebola-BDBV)
A Study to Investigate the Safety and Immunogenicity of mRNA-1469 in African Participants 1 to 65 Years of Age
The main objective of this trial is to evaluate the safety of mRNA-1469
- Trial name
- NCT07919197
- Testing
- mRNA-1469
- Where
- Uganda
- Volunteers
- 224 people, healthy volunteers welcome
- Sponsor
- ModernaTX, Inc.
Ebola-Bundibugyo Virus Disease (Ebola-BDBV)
A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants
The main objective of this trial is to evaluate the safety and reactogenicity of mRNA-1469
- Trial name
- NCT07737717
- Testing
- mRNA-1469
- Where
- 3 sites in Canada
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- ModernaTX, Inc.